REDNEW (REDNEW) fluctuates 52.6% in 24 hours: rebound amplified by low-liquidity DEX trading, no clear catalyst
Bitget Pulse2026/04/07 16:02Brief Volatility Overview
In the past 24 hours, REDNEW price rebounded from a low of $0.1588 to a high of $0.2423, currently quoted at $0.1999, with a volatility amplitude of 52.6%. According to Bitget data, a similar range saw a rebound from approximately $0.1018-$0.1058 lows to a high of $0.2252. There is currently no detailed public disclosure of 24-hour trading volume and net capital inflow/outflow data. The low liquidity DEX environment has amplified these volatility effects.
Brief Analysis of Abnormal Price Movement Causes
• Low liquidity DEX trading dominance: The price rebound was mainly amplified by a low liquidity DEX environment, lacking any significant 24-hour news events, official announcements, or large whale on-chain transactions as driving forces.
• No verifiable catalysts: No mainstream news, capital inflows, or on-chain abnormal activity were observed in the past 24 hours; the volatility appears more liquidity-driven rather than caused by fundamental events.
Market Views and Outlook
Most mainstream market opinions believe this rebound lacks a sustainable catalyst. Community sentiment is biased towards short-term FOMO with the risk of a pullback. Bitget’s analysis highlights that the low liquidity amplification effect may lead to a rapid reversal; in terms of outlook, analysts warn of overheated structures without fundamental support and recommend monitoring signals of liquidity improvement.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
